Miniatura

Fitxers

563900.pdf (828.06 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2007

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/22454

Imatinib mesylate inhibits in vitro and ex vivo biologic responses related to vascular occlusion in giant cell arteritis.

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1136/ard.2007.070805

Resum

Objectives: Ischaemic complications occur in 15–20% of patients with giant cell arteritis (GCA). The aim of our study was to explore the effect of mesenchymal growth factors expressed in GCA lesions on myointimal cell responses related to the development of intimal hyperplasia and vessel occlusion.#N##N#Methods: We developed a method to obtain primary human temporal artery derived myointimal cells (HTAMCs) based on the culture of temporal artery sections on Matrigel.#N##N#Results: Among the factors tested (platelet-derived growth factor (PDGF)-AB, fibroblast growth factor (FGF)-2, vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), transforming growth factor (TGF)β, chemokine (C-C motif) ligand (CCL)2, interleukin (IL)6 and IL1β), PDGF exhibited the strongest activity in inducing HTAMC proliferation and migration. As assessed by protein array, immunoassay and quantitative real-time reverse transcriptase (RT)-PCR, PDGF stimulated matrix proteins (collagen I, collagen III and fibronectin) as well as CCL2 and angiogenin production by HTAMCs. Imatinib mesylate inhibited PDGF-mediated activation of signalling pathways (Src, extracellular signal-regulated kinase (ERK) and Akt phosphorylation) related to cell motility and survival, efficiently resulting in inhibition of PDGF-induced HTAMC responses. Myointimal cell outgrowth from cultured temporal artery sections from patients with GCA, where multiple interactions take place, was also efficiently reduced by imatinib.#N##N#Conclusion: Among several mediators produced in GCA, PDGF has the highest vaso-occlusive potential. PDGF may also contribute to disease perpetuation by stimulating the production of angiogenic factors (angiogenin) and chemoattractants (CCL2). Imatinib mesylate strongly inhibits PDGF-mediated responses, suggesting a therapeutic potential to limit vascular occlusion and ischaemic complications in large vessel vasculitis.

Matèries

Arteritis de cèl·lules gegants, Vasos sanguinis, Factors de creixement

Matèries (anglès)

Giant cell arteritis, Blood-vessels, Growth factors

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

LOZANO GARCIA, Ester, SEGARRA BLASCO, Marta, GARCÍA MARTÍNEZ, Ana, HERNÁNDEZ RODRÍGUEZ, José, CID XUTGLÀ, M. cinta. Imatinib mesylate inhibits in vitro and ex vivo biologic responses related to vascular occlusion in giant cell arteritis.. _Annals of the Rheumatic Diseases_. 2008. Vol. 67, núm. 11, pàgs. 1581-1588. [consulta: 24 de gener de 2026]. ISSN: 0003-4967. [Disponible a: https://hdl.handle.net/2445/22454]

Exportar metadades

JSON - METS

Compartir registre